KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares Issued
Ratios

Jazz Pharmaceuticals (JAZZ) Long-Term Debt Issuances (2016 - 2017)

Historic Long-Term Debt Issuances for Jazz Pharmaceuticals (JAZZ) over the last 6 years, with Q4 2017 value amounting to -$91000.0.

  • Jazz Pharmaceuticals' Long-Term Debt Issuances rose 3000.0% to -$91000.0 in Q4 2017 from the same period last year, while for Dec 2019 it was -$91000.0, marking a year-over-year decrease of 10000.91%. This contributed to the annual value of $980.8 million for FY2024, which is N/A changed from last year.
  • Per Jazz Pharmaceuticals' latest filing, its Long-Term Debt Issuances stood at -$91000.0 for Q4 2017, which was up 3000.0% from -$130000.0 recorded in Q4 2016.
  • In the past 5 years, Jazz Pharmaceuticals' Long-Term Debt Issuances ranged from a high of $994.8 million in Q3 2016 and a low of -$2.0 million during Q3 2015
  • In the last 5 years, Jazz Pharmaceuticals' Long-Term Debt Issuances had a median value of $553.4 million in 2013 and averaged $381.3 million.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first crashed by 10036.55% in 2015, then surged by 4879197.26% in 2016.
  • Jazz Pharmaceuticals' Long-Term Debt Issuances (Quarter) stood at $553.4 million in 2013, then plummeted by 100.18% to -$981000.0 in 2014, then skyrocketed by 67.58% to -$318000.0 in 2015, then surged by 59.12% to -$130000.0 in 2016, then increased by 30.0% to -$91000.0 in 2017.
  • Its last three reported values are -$91000.0 in Q4 2017, -$130000.0 for Q4 2016, and $994.8 million during Q3 2016.